4//SEC Filing
DENYES NANCY 4
Accession 0000950170-24-069680
CIK 0001339970other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:26 AM ET
Size
5.1 KB
Accession
0000950170-24-069680
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
DENYES NANCY
General Counsel
Transactions
- Purchase
Common Stock
2024-06-05$1.86/sh+5,000$9,276→ 22,267 total
Footnotes (2)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.835 to $1.87 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 2,500 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001640869
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 8:26 AM ET
- Size
- 5.1 KB